The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
Abstract
Leukocyte adhesion to the diabetic retinal vasculature results in blood‐retinal barrier breakdown, capillary nonperfusion, and endothelial cell injury and death. Intercellular adhesion molecule‐1 (ICAM‐1) and the leukocyte integrin CD18 are required for these processes. Diabetes was induced in Long Evans rats, resulting in a two‐ to threefold increase in retinal leukocyte adhesion. Following one week of diabetes, neutrophil CD11a, CD11b, and CD18 expression was increased significantly, as were retinal ICAM‐1 levels. Animals were treated with aspirin, a cyclooxygenase 2 (COX‐2) inhibitor (meloxicam), or a soluble tumor necrosis factor α (TNF‐α) receptor/Fc construct (TNFR‐Fc, etanercept). High‐dose aspirin, etanercept, and high‐dose meloxicam each reduced leukocyte adhesion and suppressed blood‐retinal barrier breakdown. High‐dose aspirin also reduced the expression of CD11a, CD11b, and CD18, whereas meloxicam and etanercept did not. High‐dose aspirin, etanercept, and high‐dose meloxicam each reduced retinal ICAM‐1 expression. Aspirin and meloxicam both lowered retinal TNF‐α levels. Notably, aspirin, meloxicam, and etanercept did not change retinal vascular endothelial growth factor levels. High‐dose aspirin, etanercept and high‐dose meloxicam, each suppressed the retinal expression of eNOS and the DNA‐binding capacity of retinal nuclear factor‐κΒ. High‐dose aspirin also suppressed Erk kinase activity, which is involved in CD18 up‐regulation. Taken together, these data identify COX‐2 and TNF‐α as operative in the early signature pathologies of diabetic retinopathy, a newly recognized inflammatory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,379
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116778 · Cited by 1,072
Miyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Early Treatment Diabetic Retinopathy Study Design and Baseline Patient Characteristics
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38009-9 · Cited by 683
Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina
Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.-E., & Adamis, A. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63952-1 · Cited by 567
Self-citationLedebur, H. C., & Parks, T. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.933 · Cited by 545
Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119503 · Cited by 536
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum, T., Xu, Q., Joussen, A. M., Clemens, M. W., Qin, W., Miyamoto, K., Hasséssian, H., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., et al. (2001) · PubMed · Cited by 508
Kassoff, A. (1992) · JAMA · doi:10.1001/jama.1992.03490100090033 · Cited by 481
Schröder, S., Palinski, W., & Schmid‐Schönbein, G. W. (1991) · PubMed Central · Cited by 479
McLeod, D. S., Lefer, D. J., Merges, C., & Lutty, G. A. (1995) · PubMed Central · Cited by 418
Liu, S. F., Ye, X., & Malik, A. B. (1999) · Circulation · doi:10.1161/01.cir.100.12.1330 · Cited by 346
The role of oxidative stress and NF‐κB activation in late diabetic complications
Mohamed, A. K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, R., & Nawroth, P. P. (1999) · BioFactors · doi:10.1002/biof.5520100211 · Cited by 339
Miyamoto, K., Khosrof, S., Bursell, S.-E., Moromizato, Y., Aiello, L. P., Ogura, Y., & Adamis, A. P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65044-4 · Cited by 332
Yerneni, K. K., Bai, W., Khan, B. V., Medford, R. M., & Natarajan, R. (1999) · Diabetes · doi:10.2337/diabetes.48.4.855 · Cited by 328
Pierce, J. W., Read, M. A., Ding, H., Luscinskas, F. W., & Collins, T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3961 · Cited by 302
Murata, T., Nakagawa, K., Khalil, A. K., Ishibashi, T., Inomata, H., & Sueishi, K. (1996) · PubMed · Cited by 278
Sensitive blood-retinal barrier breakdown quantitation using Evans blue.
Xu, Q., Qaum, T., & Adamis, A. P. (2001) · PubMed · Cited by 274
Giraudo, E., Primo, L., Audero, E., Gerber, H.-P., Koolwijk, P., Soker, S., Klagsbrun, M., Ferrara, N., & Bussolino, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22128 · Cited by 272
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch, F. C., Miyamoto, K., Allport, J. R., Fujita, K., Bursell, S., Aiello, L. P., Luscinskas, F. W., & Adamis, A. P. (2000) · PubMed · Cited by 264
Weber, C., Erl, W., Pietsch, A., & Weber, P. C. (1995) · Circulation · doi:10.1161/01.cir.91.7.1914 · Cited by 257
Tumor Necrosis Factor-α Supports the Survival of Osteoclasts through the Activation of Akt and ERK
Lee, S. E., Chung, W. J., Kwak, H. B., Chung, C.-H., Kwack, K., Lee, Z. H., & Kim, H.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103642200 · Cited by 254
VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 239
Cell death induction by TNF: a matter of self control
Wallach, D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01015-3 · Cited by 229
Weissmann, G. (1991) · Scientific American · doi:10.1038/scientificamerican0191-84 · Cited by 229
Radisavljevic, Z., Avraham, H., & Avraham, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002448200 · Cited by 220
Pairet, M., & Engelhardt, G. (1996) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1996.tb00144.x · Cited by 213
Lim, J. W., Kim, H., & Kim, K. H. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780243 · Cited by 210
Bellas, R. E., Lee, J. S., & Sonenshein, G. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118313 · Cited by 183
Clancy, R., Varenika, B., Huang, W., Ballou, L., Attur, M., Amin, A. R., & Abramson, S. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1582 · Cited by 182
Pillinger, M. H., Capodici, C., Rosenthal, P., Kheterpal, N., Hanft, S., Philips, M. R., & Weissmann, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14540 · Cited by 181
Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human Macrophages
Ariasnegrete, S., Keller, K., & Chadee, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1378 · Cited by 181
Limb, G. A., Chignell, A. H., Green, W., LeRoy, F., & Dumonde, D. C. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.2.168 · Cited by 166
Kacimi, R., Karliner, J. S., Koudssi, F., & Long, C. S. (1998) · Circulation Research · doi:10.1161/01.res.82.5.576 · Cited by 163
Hatano, E., Bennett, B. L., Manning, A. M., Qian, T., Lemasters, J. J., & Brenner, D. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.23239 · Cited by 160
Shi, X., Ding, M., Dong, Z., Chen, F., Ye, J., Wang, S., Leonard, S. S., Castronova, V., & Vallyathan, V. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006934612368 · Cited by 158
DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS
Powell, E. D. U., & Field, R. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90008-x · Cited by 157
Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB
Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Bräutigam, L., Grösch, S., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0716fje · Cited by 153
Interaction between nitric oxide and cyclooxygenase pathways
Rosa, M. D., Ialenti, A., Ianaro, A., & Sautebin, L. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90053-8 · Cited by 139
Williams, B., & Schrier, R. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116911 · Cited by 139
Autieri, M. V., Yue, T. L., Ferstein, G. Z., et al. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2204 · Cited by 134
Chew, E. Y., Klein, M. L., Murphy, R. P., Remaley, N. A., & Ferris, F. L. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100010054020 · Cited by 120
Penglis, P. S., Cleland, L. G., Demasi, M., Caughey, G. E., & James, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1605 · Cited by 108
Moynagh, P. N., Williams, D. C., & O'Neill, L. A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2681 · Cited by 104
Amrani, Y., Lazaar, A. L., & Panettieri, R. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2128 · Cited by 104
Zouki, C., Zhang, S., Chan, J. S. D., & Filep, J. G. (2000) · The FASEB Journal · doi:10.1096/fj.00-0521fje · Cited by 90
do Carmo, A., Cunha-Vaz, J. G., Carvalho, A. P., & Lopes, M. C. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0312 · Cited by 89
Superoxide Production and Reactive Oxygen Species Signaling by Endothelial Nitric-oxide Synthase
Wang, W., Wang, S., Liang, Y., Madara, P., Cintron, A. D. P., WESLEY, R. A., & Danner, R. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000301200 · Cited by 88
Limb, G. A., Webster, L., Soomro, H., Janikoun, S., & Shilling, J. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.01067.x · Cited by 71
Anti-TNF agents in Crohn’s disease
Assche, G. V., & Rutgeerts, P. J. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.1.103 · Cited by 64
Najarian, T., Marrache, A. M., Dumont, I. J., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1149 · Cited by 63
Cytokines in rheumatoid arthritis: trials and tribulations
Carteron, N. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01757-3 · Cited by 59
Review of Clinical Trials and Benefit/Risk Ratio of Meloxicam
Barner, A. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609097228 · Cited by 55
Hawrami, K., Hitman, G. A., Rema, M., et al. (1996) · Human Immunology · doi:10.1016/0198-8859(95)00177-8 · Cited by 53
Limb, G. A., Soomro, H., Janikoun, S., Hollifield, R. D., & Shilling, J. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00839.x · Cited by 51
Moreland, L. W., McCabe, D., Caldwell, J. R., Sack, M. R., Weisman, M. H., Henry, G., Seely, J. E., Martin, S. W., Yee, C. L., Bendele, A. M., et al. (2000) · PubMed · Cited by 44
Dumont, I., Hou, X., Hardy, P., Peri, K. G., Beauchamp, M., Najarian, T., Molotchnikoff, S., Varma, D. R., & Chemtob, S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35148-1 · Cited by 43
Tummala, P. E., Chen, X.-L., & Medford, R. M. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1183 · Cited by 33
Treatment Options for Rheumatoid Arthritis: Celecoxib, Leflunomide, Etanercept, and Infliximab
Luong, B. T., Chong, B. S., & Lowder, D. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19344 · Cited by 29
Chen, L., Rao, A., & Harrison, S. C. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.527 · Cited by 27
The role of cytokines and prostaglandin-E2 in thymulin induced hyperalgesia
Safieh‐Garabedian, B., Dardenne, M., Kanaan, S. A., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00247-6 · Cited by 26
McCormack, K. (1998) · PubMed · Cited by 11
Effect of aspirin on platelet aggregation in diabetes mellitus
Khosla, P. K., Seth, V., Tiwari, H. K., & Saraya, A. K. (1982) · Diabetologia · doi:10.1007/bf01271169 · Cited by 10
Cited by
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Frank, R. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmra021678 · Cited by 891
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 874
Metadata
- Authors
- M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-01-30
- Volume
- 16
- Issue
- 3
- Pages
- 438-440
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2160121103
- Cited by
- 567
- References
- 66
- FWCI
- 24.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.